News Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days pharminent July 1, 2026
News NEJM Retracts Pivotal Tavneos Paper as Amgen’s FDA Data-Integrity Fight Deepens pharminent June 30, 2026
News Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease pharminent June 29, 2026
